The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

Research supports that both finasteride and dutasteride help treat hair loss, particularly when caused by androgenetic ...

CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani: Shardul Nautiyal, Mumbai ...

Nigeria records over 18,000 new prostate cancer cases annually, accounting for the highest cancer burden among men in the country.

Testosterone is a hormone that supports muscle mass, bone strength, mood, cardiovascular health, and intimate health. Low testosterone can contribute to symptoms like fatigue, … ...

Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...

UCHealth hospital uses BPH AI to guide aquablation, improving precision and preserving sexual function in prostate treatment.

In a trial, the newly approval urethral stent provided significant and durable relief of BPH-related LUTS over 12 months. The FDA has approved the ProVee® System for treatment of benign prostatic ...

Stemcell United Ltd. ( (AU:BP8)) has provided an announcement. BPH Global Ltd, listed on the ASX under ticker BP8, has reported a change in its issued capital structure following the expiry of certain ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...